Head to head
Spravato vs Ketamine oral
A side-by-side look at Spravato (esketamine) and Ketamine oral/lozenge across the factors that actually change your decision: cost, setting, insurance, evidence, and the kind of clinician who runs the room.
Factor
Spravato
Ketamine oral
Legal status
FDA-approved 2019
Off-label (telehealth prescribing rules apply)
Setting
REMS-certified site, 2-hour observation
At home, telehealth supervised
Session length
~2.5 hours
45-90 min
Insurance coverage
Commonly covered for TRD
Not covered; HSA/FSA eligible
Typical cost / session
$0-$950 (insurance-dependent)
$150-$300/month
Induction / course
8 sessions over 4 weeks
Daily-weekly dosing, variable
Evidence base
Phase 3 RCTs; FDA approved
Moderate, usually with therapy
Who administers
Psychiatrist / nurse practitioner at REMS site
Telehealth prescriber + therapist
Risk of abuse / dependency
Schedule III, REMS-controlled
Higher (take-home exposure)
Verified Spravato providers
12
Verified Ketamine oral providers
2